Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
1.155
-0.025 (-2.12%)
Dec 4, 2024, 2:38 PM EST - Market open
Tevogen Bio Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -7.92 | -60.48 | -22.04 | -15.6 |
| Depreciation & Amortization | 0.4 | 0.38 | 0.23 | 0.01 |
| Stock-Based Compensation | 33.8 | - | 4.58 | 0.58 |
| Other Operating Activities | -38.69 | 51.64 | 8.32 | 10.98 |
| Change in Accounts Payable | 2.67 | 1.11 | 0.35 | -1.09 |
| Change in Other Net Operating Assets | -2 | -0.82 | -0.1 | -0.16 |
| Operating Cash Flow | -10.93 | -8.17 | -8.66 | -5.27 |
| Capital Expenditures | - | -0.13 | -0.48 | -0.11 |
| Investing Cash Flow | - | -0.13 | -0.48 | -0.11 |
| Long-Term Debt Issued | - | 4 | 7.5 | 12.5 |
| Net Debt Issued (Repaid) | 1.35 | 4 | 7.5 | 12.5 |
| Other Financing Activities | 0.3 | -0.13 | - | - |
| Financing Cash Flow | 10.65 | 3.87 | 7.5 | 12.5 |
| Net Cash Flow | -0.28 | -4.43 | -1.63 | 7.12 |
| Free Cash Flow | -10.93 | -8.3 | -9.13 | -5.38 |
| Free Cash Flow Per Share | -0.09 | -0.34 | -0.36 | -0.21 |
| Levered Free Cash Flow | 8.62 | -3.52 | -4.11 | - |
| Unlevered Free Cash Flow | 8.92 | -2.77 | -3.53 | - |
| Change in Net Working Capital | -2.8 | -2.51 | -0.72 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.